vs
Side-by-side financial comparison of Critical Metals Corp. (CRML) and PureTech Health plc (PRTC). Click either name above to swap in a different company.
Critical Metals Corp. is the larger business by last-quarter revenue ($359.9K vs $180.0K, roughly 2.0× PureTech Health plc). Critical Metals Corp. runs the higher net margin — -5262.2% vs -22820.6%, a 17558.4% gap on every dollar of revenue.
Metlen Energy & Metals is a global industrial and energy company operating two business Sectors: Energy and Metallurgy. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index
PureTech Health plcPRTCEarnings & Financial Report
PureTech Health is an American biotechnology company which develops medicines to combat serious diseases. It is listed on the London Stock Exchange.
CRML vs PRTC — Head-to-Head
Income Statement — Q4 FY2024 vs Q4 FY2023
| Metric | | |
|---|---|---|
| Revenue | $359.9K | $180.0K |
| Net Profit | $-18.9M | $-41.1M |
| Gross Margin | — | — |
| Operating Margin | — | -38908.9% |
| Net Margin | -5262.2% | -22820.6% |
| Revenue YoY | — | — |
| Net Profit YoY | — | — |
| EPS (diluted) | $-0.21 | $-0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $149.5K | $191.1M |
| Total DebtLower is stronger | — | $0 |
| Stockholders' EquityBook value | $77.1M | $458.2M |
| Total Assets | $146.3M | $694.0M |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 24 | $149.5K | — | ||
| Q4 23 | — | $191.1M |
| Q4 24 | — | — | ||
| Q4 23 | — | $0 |
| Q4 24 | $77.1M | — | ||
| Q4 23 | — | $458.2M |
| Q4 24 | $146.3M | — | ||
| Q4 23 | — | $694.0M |
| Q4 24 | — | — | ||
| Q4 23 | — | 0.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.6M | $-40.8M |
| Free Cash FlowOCF − Capex | $-2.6M | — |
| FCF MarginFCF / Revenue | -719.7% | — |
| Capex IntensityCapex / Revenue | 0.3% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 24 | $-2.6M | — | ||
| Q4 23 | — | $-40.8M |
| Q4 24 | $-2.6M | — | ||
| Q4 23 | — | — |
| Q4 24 | -719.7% | — | ||
| Q4 23 | — | — |
| Q4 24 | 0.3% | — | ||
| Q4 23 | — | 0.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
